Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group studyAlan F. List, Frederick R. Appelbaum, Diane L. Persons et al.|Blood|2001Cited by 419
A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a Southwest Oncology Group study 9617Thomas R. Chauncey, Frederick R. Appelbaum, Cathryn Rankin et al.|Leukemia Research|2000Cited by 56